Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Wednesday, August 10, 2022.

Atea Pharmaceuticals, Inc. - common stock (NASDAQ:AVIR)

Long-Term Uptrend (+90) - AVIR is in a strong uptrend that is likely to continue. While AVIR is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.

Is it time to buy, sell, or avoid AVIR?

MarketClub looks at technical strength and momentum to determine if the timing is right for AVIR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_AVIR
Open High Low AVIR Price Change
8.82 9.79 8.33 8.48 -0.11
Entry Signal

MarketClub’s Trade Triangles for AVIR

long term up The long-term trend has been UP since May 17th, 2022 at 7.5012

intermediate term up The intermediate-term trend has been UP since Jul 5th, 2022 at 7.5100

short term up The short-term trend has been UP since Aug 1st, 2022 at 8.2700

Smart Scan Analysis for AVIR

Based on our trend formula, AVIR is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

+90
Smart Scan Analysis for AVIR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
8.82 9.79 8.33 8.48 -0.11
Prev. Close Volume Bid Ask Time
8.48 797842 2022-08-09 15:59:48
52wk High46.909952wk High Date2021-10-04
52wk Low5.3152wk Low Date2022-05-09
Average Volume349,660Shares Outstanding83,226
Assets717,189,000MLiabilities37,305,000M
P/E Ratio17.5306
Get a free daily analysis and signals for Atea Pharmaceuticals, Inc. - common stock (AVIR) - Request Your Free Report.